| NCT Number | NCT06954571 |
| Lead Sponsor | Tianjin Medical University Second Hospital |
| Conditions | Renal Tumors |
| Enrollment | 190 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2024-11-30 (estimated) |
| Study Completion | 2025-08-01 (estimated) |
| Updated on ClinicalTrials.gov | 2025-05-11 |